(S)-2-amino-2-methylbutan-1-ol | 22464-36-4

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: (S)-2-amino-2-methylbutan-1-ol
• 英文别名: (2S)-2-Amino-2-methylbutan-1-ol
• CAS: 22464-36-4
• 化学式: C₅H₁₃NO
• mdl: MFCD09759242
• 分子量: 103.164
• InChiKey: QHKGDMNPQAZMKD-YFKPBYRVSA-N

物化性质

• 沸点：
  186.8±13.0 °C(Predicted)
• 密度：
  0.918±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.3
• 重原子数：
  7
• 可旋转键数：
  2
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  46.2
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 海关编码：
  2922199090

反应信息

• 作为反应物：
  描述：

  (S)-2-amino-2-methylbutan-1-ol 、 (S)-N-(1-((tert-butyldiphenylsilyl)oxy)butan-2-yl)-2-chloroacetamide 在 N,N-二异丙基乙胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 14.0h， 以29%的产率得到
  参考文献：
  名称：

  Design, synthesis, and evaluation of novel ethambutol analogues

  摘要：

  Ethambutol is one of the front-line agents recommended by the World Health Organization for the treatment of tuberculosis. In an effort to develop more potent therapies to treat tuberculosis, novel unsymmetrical ethambutol analogues were successfully synthesized by a new route utilizing novel building blocks synthesized using Ellman's sulfinyl chemistry. The resulting analogues were tested for anti-tuberculosis activity yielding compounds with comparable anti-tuberculosis activity to ethambutol and increased lipophilicity that may instill better tissue penetration and serum half-life. (c) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2008.01.065
• 作为产物：
  描述：

  (R_S,1S)-2-methylpropane-2-sulfinic acid [1-((tert-butyldimethylsilanyloxy)methyl)-1-methylpropyl]amide 在 盐酸 作用下， 以 1,4-二氧六环 、 甲醇 为溶剂， 反应 0.5h， 生成 (S)-2-amino-2-methylbutan-1-ol
  参考文献：
  名称：

  使用叔丁烷亚磺酰基醛亚胺和酮亚胺的不对称合成受保护的1,2-氨基醇。

  摘要：

  带有α-苄氧基或α-甲硅烷氧基取代基的叔丁烷亚磺酰基醛亚胺和酮亚胺以高收率和非对映选择性用作合成被保护的1,2-氨基醇的前体。描述了将非支链烷基，支链烷基和芳基有机金属试剂添加到N-亚磺酰基醛亚胺1和2以及酮亚胺5和6中的一般规程。此外，亚氨基酰胺产物3、4、7的选择性N-或O-脱保护描述了图8和8，使得能够进一步合成反应产物。

  DOI：

  10.1021/jo0156868

文献信息

• Asymmetric Synthesis of Protected 1,2-Amino Alcohols Using <i>tert</i>-Butanesulfinyl Aldimines and Ketimines
  作者：Tony P. Tang、Steven K. Volkman、Jonathan A. Ellman

  DOI：10.1021/jo0156868

  日期：2001.12.1

  tert-Butanesulfinyl aldimines and ketimines bearing an alpha-benzyloxy or alpha-silyloxy substituent serve as precursors in the synthesis of protected 1,2-amino alcohols in high yields and diastereoselectivities. General protocols are described for the addition of unbranched alkyl, branched alkyl, and aryl organometallic reagents to N-sulfinyl aldimines 1 and 2 and ketimines 5 and 6. Furthermore, the

  带有α-苄氧基或α-甲硅烷氧基取代基的叔丁烷亚磺酰基醛亚胺和酮亚胺以高收率和非对映选择性用作合成被保护的1,2-氨基醇的前体。描述了将非支链烷基，支链烷基和芳基有机金属试剂添加到N-亚磺酰基醛亚胺1和2以及酮亚胺5和6中的一般规程。此外，亚氨基酰胺产物3、4、7的选择性N-或O-脱保护描述了图8和8，使得能够进一步合成反应产物。
• Palladium-Catalyzed Ring Opening of Isoprene Monoxide with Nitrogen Nucleophiles - Asymmetric Synthesis of Branched Amino Sugars
  作者：Barry M. Trost、Chunhui Jiang、Kristin Hammer

  DOI：10.1055/s-2005-918443

  日期：——

  The Pd-catalyzed regio- and enantioselective ring opening of isoprene monoxide with primary amines as pronucleophiles is developed with good yield and enantioselectivity, constructing a quaternary stereocenter enantioselectively. This methodology was used as the chirality inducing key step in the asymmetric synthesis of vancosamine derivative 19. The synthesis was achieved in 9 total steps and 28.6%

  以伯胺为亲核试剂的 Pd 催化区域和对映选择性开环一氧化异戊二烯具有良好的收率和对映选择性，构建了四元立体中心对映选择性。该方法被用作万可胺衍生物 19 不对称合成中的手性诱导关键步骤。该合成在 9 个总步骤中实现，总产率为 28.6%。
• Design, synthesis, and evaluation of novel ethambutol analogues
  作者：Raghunandan Yendapally、Richard E. Lee

  DOI：10.1016/j.bmcl.2008.01.065

  日期：2008.3

  Ethambutol is one of the front-line agents recommended by the World Health Organization for the treatment of tuberculosis. In an effort to develop more potent therapies to treat tuberculosis, novel unsymmetrical ethambutol analogues were successfully synthesized by a new route utilizing novel building blocks synthesized using Ellman's sulfinyl chemistry. The resulting analogues were tested for anti-tuberculosis activity yielding compounds with comparable anti-tuberculosis activity to ethambutol and increased lipophilicity that may instill better tissue penetration and serum half-life. (c) 2008 Elsevier Ltd. All rights reserved.